Botox May Ease Tremors in Multiple Sclerosis Patients
MONDAY July 2, 2012 -- The drug Botox, best known for paralyzing muscles in the forehead to reduce wrinkles, can also relieve shaking in the limbs of patients with multiple sclerosis, a small new study suggests.
The treatment, which requires several times the amount of Botox (botulinum toxin type A) used for wrinkles, could be expensive and it's not yet approved by the U.S. Food and Drug Administration for this use. However, multiple sclerosis (MS) patients can still legally get the treatment in the United States.
"Most patients tolerate the injections very well and are keen to continue the treatment once they see the benefits they get from it," said Dr. Anneke van der Walt, lead study author and a neurologist and research fellow at the Royal Melbourne Hospital, in Australia.
The shaking, known as a tremor, can affect one or both arms, or less commonly the legs, in MS patients. "The shaking affects them when they're just trying to hold the arms up or do common daily tasks such as eating and drinking, shaving and, particularly, writing," van der Walt said. "As with many MS symptoms, the tremor can be worse on very hot days and worse when the person is tired."
Physicians may turn to medications to treat the tremors, but the drugs often have little effect, van der Walt said. Brain surgery to implant electrodes is another option to relieve the tremors, but the benefits may not last long.
In the new study, researchers randomly gave Botox or an inactive placebo by injection to 23 MS patients with tremors in their arms. Twelve weeks later, they reversed the injections so each arm ultimately received both Botox and placebo.
The investigators assessed tremor severity and a variety of motor skills before and after treatment.
According to the study, published in the July 3 issue of the journal Neurology, after Botox injection, the patients had "significant" improvement in tremors as well as in drawing and writing ability, as rated on a 10-point scale.
One side effect, weakness in the limb, was very common in the patients who received Botox -- 42 percent reported it, compared with 6 percent among those who received the placebo. However, the weakness was mild to moderate in the patients and went away within two weeks.
It's not clear how the drug relieves tremors, but it may have something to do with changing the way muscles, nerves and the brain interact, van der Walt said.
The patients received an average of 83 international units of Botox, about three to four times the amount used for wrinkles, although less than the typical amount that migraine patients get. The injections are needed from two to four times a year and cost the equivalent of about $500 to $1,000 in Australia, van der Walt said.
She recommended that "patients who are interested in exploring Botox treatment for their tremor [should] make sure that they are referred to a movement disorder specialist with both an interest in tremor and expertise in complex Botox injections."
Commenting on the study, Dr. Thomas Guttuso Jr., an assistant professor of neurology at the University at Buffalo in New York, said Botox currently is usually reserved for patients with severe, continuing tremor "that is markedly interfering with certain activities of daily living."
Guttuso added, "My own experience with these patients is that Botox can be effective when the tremor occurs more at the shoulders and elbows but not as effective when the tremor occurs more at the wrists and fingers."
He added that it's not clear if Botox leads to "meaningful" differences in the lives of patients, and future research will need to examine that issue.
For more about multiple sclerosis, visit the U.S. National Library of Medicine.
Posted: July 2012